| Product Code: ETC9681095 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Chemotherapy-Induced Peripheral Neuropathy Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Chemotherapy-Induced Peripheral Neuropathy Market - Industry Life Cycle |
3.4 Thailand Chemotherapy-Induced Peripheral Neuropathy Market - Porter's Five Forces |
3.5 Thailand Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Thailand Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Thailand Chemotherapy-Induced Peripheral Neuropathy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Thailand leading to higher chemotherapy usage |
4.2.2 Growing awareness about chemotherapy-induced peripheral neuropathy among healthcare professionals and patients |
4.2.3 Technological advancements in the field of oncology leading to the development of more effective chemotherapy drugs |
4.3 Market Restraints |
4.3.1 High cost associated with the treatment of chemotherapy-induced peripheral neuropathy |
4.3.2 Lack of skilled healthcare professionals specialized in managing chemotherapy-induced peripheral neuropathy in Thailand |
5 Thailand Chemotherapy-Induced Peripheral Neuropathy Market Trends |
6 Thailand Chemotherapy-Induced Peripheral Neuropathy Market, By Types |
6.1 Thailand Chemotherapy-Induced Peripheral Neuropathy Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Thailand Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Thailand Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Steroids, 2021- 2031F |
6.1.4 Thailand Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Antidepressants, 2021- 2031F |
6.1.5 Thailand Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Anti-Seizure, 2021- 2031F |
6.1.6 Thailand Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Narcotics, 2021- 2031F |
6.2 Thailand Chemotherapy-Induced Peripheral Neuropathy Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Thailand Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.2.3 Thailand Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.2.4 Thailand Chemotherapy-Induced Peripheral Neuropathy Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Thailand Chemotherapy-Induced Peripheral Neuropathy Market Import-Export Trade Statistics |
7.1 Thailand Chemotherapy-Induced Peripheral Neuropathy Market Export to Major Countries |
7.2 Thailand Chemotherapy-Induced Peripheral Neuropathy Market Imports from Major Countries |
8 Thailand Chemotherapy-Induced Peripheral Neuropathy Market Key Performance Indicators |
8.1 Patient satisfaction with neuropathy management services |
8.2 Number of clinical trials focusing on new treatments for chemotherapy-induced peripheral neuropathy |
8.3 Adoption rate of updated clinical guidelines for managing chemotherapy-induced peripheral neuropathy in Thailand |
9 Thailand Chemotherapy-Induced Peripheral Neuropathy Market - Opportunity Assessment |
9.1 Thailand Chemotherapy-Induced Peripheral Neuropathy Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Thailand Chemotherapy-Induced Peripheral Neuropathy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Thailand Chemotherapy-Induced Peripheral Neuropathy Market - Competitive Landscape |
10.1 Thailand Chemotherapy-Induced Peripheral Neuropathy Market Revenue Share, By Companies, 2024 |
10.2 Thailand Chemotherapy-Induced Peripheral Neuropathy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here